Literature DB >> 17965927

The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore.

S Y Lim1, S M Davidson, M M Mocanu, D M Yellon, C C T Smith.   

Abstract

BACKGROUND: Necrostatin (Nec-1) protects against ischemia-reperfusion (IR) injury in both brain and heart. We have previously reported in this journal that necrostatin can delay opening of the mitochondrial permeability transition pore (MPTP) in isolated cardiomyocytes. AIM: The aim of the present study was to investigate in more detail the role played by the MPTP in necrostatin-mediated cardioprotection employing mice lacking a key component of the MPTP, namely cyclophilin-D.
METHOD: Anaesthetized wild type (WT) and cyclophilin-D knockout (Cyp-D-/-) mice underwent an open-chest procedure involving 30 min of myocardial ischemia and 2 h of reperfusion, with subsequent infarct size assessed by triphenyltetrazolium staining. Nec-1, given at reperfusion, significantly limited infarct size in WT mice (17.7 +/- 3% vs. 54.3 +/- 3%, P < 0.05) but not in Cyp-D-/- mice (28.3 +/- 7% vs. 30.8 +/- 6%, P > 0.05).
CONCLUSION: The data obtained in Cyp-D-/- mice provide further evidence that Nec-1 protects against myocardial IR injury by modulating MPTP opening at reperfusion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17965927      PMCID: PMC2874660          DOI: 10.1007/s10557-007-6067-6

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  12 in total

1.  Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury.

Authors:  Alexei Degterev; Zhihong Huang; Michael Boyce; Yaqiao Li; Prakash Jagtap; Noboru Mizushima; Gregory D Cuny; Timothy J Mitchison; Michael A Moskowitz; Junying Yuan
Journal:  Nat Chem Biol       Date:  2005-05-29       Impact factor: 15.040

2.  Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D.

Authors:  Emy Basso; Lisa Fante; Jonathan Fowlkes; Valeria Petronilli; Michael A Forte; Paolo Bernardi
Journal:  J Biol Chem       Date:  2005-03-25       Impact factor: 5.157

3.  Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death.

Authors:  Christopher P Baines; Robert A Kaiser; Nicole H Purcell; N Scott Blair; Hanna Osinska; Michael A Hambleton; Eric W Brunskill; M Richard Sayen; Roberta A Gottlieb; Gerald W Dorn; Jeffrey Robbins; Jeffery D Molkentin
Journal:  Nature       Date:  2005-03-31       Impact factor: 49.962

4.  Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death.

Authors:  Takashi Nakagawa; Shigeomi Shimizu; Tetsuya Watanabe; Osamu Yamaguchi; Kinya Otsu; Hirotaka Yamagata; Hidenori Inohara; Takeshi Kubo; Yoshihide Tsujimoto
Journal:  Nature       Date:  2005-03-31       Impact factor: 49.962

5.  Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury.

Authors:  Laurent Argaud; Odile Gateau-Roesch; Danina Muntean; Lara Chalabreysse; Joseph Loufouat; Dominique Robert; Michel Ovize
Journal:  J Mol Cell Cardiol       Date:  2005-01-26       Impact factor: 5.000

6.  Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia.

Authors:  Anna C Schinzel; Osamu Takeuchi; Zhihong Huang; Jill K Fisher; Zhipeng Zhou; Jeffery Rubens; Claudio Hetz; Nika N Danial; Michael A Moskowitz; Stanley J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-15       Impact factor: 11.205

7.  Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury.

Authors:  Derek J Hausenloy; Michael R Duchen; Derek M Yellon
Journal:  Cardiovasc Res       Date:  2003-12-01       Impact factor: 10.787

8.  Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion.

Authors:  E J Griffiths; A P Halestrap
Journal:  Biochem J       Date:  1995-04-01       Impact factor: 3.857

Review 9.  Preconditioning and postconditioning: united at reperfusion.

Authors:  Derek J Hausenloy; Derek M Yellon
Journal:  Pharmacol Ther       Date:  2007-06-30       Impact factor: 12.310

10.  Protection by Cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts.

Authors:  E J Griffiths; A P Halestrap
Journal:  J Mol Cell Cardiol       Date:  1993-12       Impact factor: 5.000

View more
  62 in total

1.  An alternative mitophagy pathway mediated by Rab9 protects the heart against ischemia.

Authors:  Toshiro Saito; Jihoon Nah; Shin-Ichi Oka; Risa Mukai; Yoshiya Monden; Yasuhiro Maejima; Yoshiyuki Ikeda; Sebastiano Sciarretta; Tong Liu; Hong Li; Erdene Baljinnyam; Diego Fraidenraich; Luke Fritzky; Peiyong Zhai; Shizuko Ichinose; Mitsuaki Isobe; Chiao-Po Hsu; Mondira Kundu; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2019-01-22       Impact factor: 14.808

Review 2.  Mechanisms of cell death in heart disease.

Authors:  Klitos Konstantinidis; Russell S Whelan; Richard N Kitsis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-17       Impact factor: 8.311

Review 3.  Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease.

Authors:  Dominic P Del Re; Dulguun Amgalan; Andreas Linkermann; Qinghang Liu; Richard N Kitsis
Journal:  Physiol Rev       Date:  2019-10-01       Impact factor: 37.312

4.  Inhibition of programmed necrosis limits infarct size through altered mitochondrial and immune responses in the aged female rat heart.

Authors:  Alexandra M Garvin; Morgan A Jackson; Donna H Korzick
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-06-29       Impact factor: 4.733

Review 5.  Regulated necrosis: the expanding network of non-apoptotic cell death pathways.

Authors:  Tom Vanden Berghe; Andreas Linkermann; Sandrine Jouan-Lanhouet; Henning Walczak; Peter Vandenabeele
Journal:  Nat Rev Mol Cell Biol       Date:  2014-02       Impact factor: 94.444

6.  NO donor induces Nec-1-inhibitable, but RIP1-independent, necrotic cell death in pancreatic β-cells.

Authors:  Yoshiaki Tamura; Yuko Chiba; Toshihiro Tanioka; Nobuyuki Shimizu; Shohei Shinozaki; Marina Yamada; Kentaro Kaneki; Seijiro Mori; Atsushi Araki; Hideki Ito; Masao Kaneki
Journal:  FEBS Lett       Date:  2011-08-28       Impact factor: 4.124

7.  Intermediate domain of receptor-interacting protein kinase 1 (RIPK1) determines switch between necroptosis and RIPK1 kinase-dependent apoptosis.

Authors:  Linde Duprez; Mathieu J M Bertrand; Tom Vanden Berghe; Yves Dondelinger; Nele Festjens; Peter Vandenabeele
Journal:  J Biol Chem       Date:  2012-02-23       Impact factor: 5.157

8.  Combination of necroptosis and apoptosis inhibition enhances cardioprotection against myocardial ischemia-reperfusion injury.

Authors:  Shizuka Koshinuma; Masami Miyamae; Kazuhiro Kaneda; Junichiro Kotani; Vincent M Figueredo
Journal:  J Anesth       Date:  2013-10-11       Impact factor: 2.078

Review 9.  RIP kinases: key decision makers in cell death and innate immunity.

Authors:  F Humphries; S Yang; B Wang; P N Moynagh
Journal:  Cell Death Differ       Date:  2014-08-22       Impact factor: 15.828

10.  Sexual dimorphism in BDNF signaling after neonatal hypoxia-ischemia and treatment with necrostatin-1.

Authors:  R Chavez-Valdez; L J Martin; S Razdan; E B Gauda; F J Northington
Journal:  Neuroscience       Date:  2013-12-17       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.